Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nonmedical use of prescription drugs in the European Union
Scott P. Novak, Anders Håkansson, José Martínez‐Raga, et al.
BMC Psychiatry (2016) Vol. 16, Iss. 1
Open Access | Times Cited: 157

Showing 1-25 of 157 citing articles:

Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development
Eduardo Ekman Schenberg
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 187
Advances in Achieving Opioid Analgesia Without Side Effects
Halina Machelska, Melih Ö. Celik
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 153
The opioid epidemic and national guidelines for opioid therapy for chronic noncancer pain: a perspective from different continents
Winfried Häuser, Stephan A. Schug, Andrea D Furlan
PAIN Reports (2017) Vol. 2, Iss. 3, pp. e599-e599
Open Access | Times Cited: 142
Therapy-Related Explants After Spinal Cord Stimulation: Results of an International Retrospective Chart Review Study
Jean‐Pierre Van Buyten, Frank Wille, Iris Smet, et al.
Neuromodulation Technology at the Neural Interface (2017) Vol. 20, Iss. 7, pp. 642-649
Open Access | Times Cited: 124
Guidelines for Opioid Prescribing in Children and Adolescents After Surgery
Lorraine I. Kelley‐Quon, Matthew G. Kirkpatrick, Robert L. Ricca, et al.
JAMA Surgery (2020) Vol. 156, Iss. 1, pp. 76-76
Open Access | Times Cited: 113
Opioid misuse in gastroenterology and non-opioid management of abdominal pain
Eva Szigethy, Mitchell R. Knisely, Douglas A. Drossman
Nature Reviews Gastroenterology & Hepatology (2017) Vol. 15, Iss. 3, pp. 168-180
Open Access | Times Cited: 106
The source and diversion of pharmaceutical drugs for non-medical use: A systematic review and meta-analysis
Shann Hulme, David Bright, Suzanne Nielsen
Drug and Alcohol Dependence (2018) Vol. 186, pp. 242-256
Closed Access | Times Cited: 85
Focus on Over-the-Counter Drugs' Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants
Fabrizio Schifano, Stefania Chiappini, Andrea Miuli, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 81
A Global Perspective on Promoting Workplace Mental Health and the Role of Employee Assistance Programs
Mark Attridge
American Journal of Health Promotion (2019) Vol. 33, Iss. 4, pp. 622-629
Closed Access | Times Cited: 79
Tackling Counterfeit Drugs: The Challenges and Possibilities
Ranjana Pathak, Vaibhav Gaur, Himanshu Sankrityayan, et al.
Pharmaceutical Medicine (2023) Vol. 37, Iss. 4, pp. 281-290
Open Access | Times Cited: 36
Balancing opioid analgesia with the risk of nonmedical opioid use in patients with cancer
Joseph Arthur, Éduardo Bruera
Nature Reviews Clinical Oncology (2018) Vol. 16, Iss. 4, pp. 213-226
Closed Access | Times Cited: 73
Assessing the 2004–2018 Fentanyl Misusing Issues Reported to an International Range of Adverse Reporting Systems
Fabrizio Schifano, Stefania Chiappini, John Corkery, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 54
What about “Pharming”? Issues Regarding the Misuse of Prescription and Over-the-Counter Drugs
Stefania Chiappini, Fabrizio Schifano
Brain Sciences (2020) Vol. 10, Iss. 10, pp. 736-736
Open Access | Times Cited: 47
Beyond the ‘purple drank’: Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports
Stefania Chiappini, Fabrizio Schifano, John Corkery, et al.
Journal of Psychopharmacology (2021) Vol. 35, Iss. 6, pp. 681-692
Open Access | Times Cited: 40
Online Pharmacies Selling Prescription Drugs: Systematic Review
Chiau Soon Long, Harshily Kumaran, Khang Wen Goh, et al.
Pharmacy (2022) Vol. 10, Iss. 2, pp. 42-42
Open Access | Times Cited: 35
Profiles of College Students Who Engage in Nonmedical Use of Prescription Drugs: Association with Frustration Intolerance Beliefs
Catherine Potard
Journal of College Student Mental Health (2025), pp. 1-19
Closed Access
Treatment of Chronic Pain With Various Buprenorphine Formulations: A Systematic Review of Clinical Studies
Rohit Aiyer, Amitabh Gulati, Semih Güngör, et al.
Anesthesia & Analgesia (2017) Vol. 127, Iss. 2, pp. 529-538
Closed Access | Times Cited: 57
Opioid prescribing for chronic musculoskeletal pain in UK primary care: results from a cohort analysis of the COPERS trial
Tomi Ashaye, Natalia Hounsome, Dawn Carnes, et al.
BMJ Open (2018) Vol. 8, Iss. 6, pp. e019491-e019491
Open Access | Times Cited: 57
Trastorno por uso de sustancias: epidemiología, complicaciones médicas y tratamiento
Daniel Fuster, Paola Zuluaga, Roberto Muga
Medicina Clínica (2024) Vol. 162, Iss. 9, pp. 431-438
Closed Access | Times Cited: 4
Nonmedical prescription psychiatric drug use and the darknet: A cryptomarket analysis
Jack Cunliffe, David Décary‐Hétu, Thomas A. Pollak
International Journal of Drug Policy (2019) Vol. 73, pp. 263-272
Open Access | Times Cited: 40
Pharmacogenetics of Opioid Use Disorder Treatment
Richard C. Crist, Toni‐Kim Clarke, Wade H. Berrettini
CNS Drugs (2018) Vol. 32, Iss. 4, pp. 305-320
Open Access | Times Cited: 38
“With tramadol, I ride like a Jaguar”: a qualitative study of motivations for non-medical purpose tramadol use among commercial vehicle operators in Kumasi, Ghana
Prince Peprah, Williams Agyemang‐Duah, Emmanuel Appiah-Brempong, et al.
Substance Abuse Treatment Prevention and Policy (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 33
Misuse of Anticholinergic Medications: A Systematic Review
Stefania Chiappini, Alessio Mosca, Andrea Miuli, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 355-355
Open Access | Times Cited: 19
Attention-deficit hyperactivity disorder medication use: factors involved in prescribing, safety aspects and outcomes
José Martínez‐Raga, Amparo Ferreros, Carlos Knecht, et al.
Therapeutic Advances in Drug Safety (2016) Vol. 8, Iss. 3, pp. 87-99
Open Access | Times Cited: 34
Prevalence of prescription opioid use disorder among chronic opioid therapy patients after health plan opioid dose and risk reduction initiatives
Michael Von Korff, Rod Walker, Kathleen Saunders, et al.
International Journal of Drug Policy (2017) Vol. 46, pp. 90-98
Closed Access | Times Cited: 33
Page 1 - Next Page

Scroll to top